Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention

Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor subtype γ (PPARγ) activators that are clinically used as an insulin sensitizer for glycemic control in patients with type 2 diabetes. Additionally, TZDs exhibit novel anti-inflammatory, antioxidant, and antiproliferative proper...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianxin Yang, Sunhapas Soodvilai
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2008/943614
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567795250888704
author Tianxin Yang
Sunhapas Soodvilai
author_facet Tianxin Yang
Sunhapas Soodvilai
author_sort Tianxin Yang
collection DOAJ
description Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor subtype γ (PPARγ) activators that are clinically used as an insulin sensitizer for glycemic control in patients with type 2 diabetes. Additionally, TZDs exhibit novel anti-inflammatory, antioxidant, and antiproliferative properties, indicating therapeutic potential for a wide variety of diseases associated with diabetes and other conditions. The clinical applications of TZDs are limited by the common major side effect of fluid retention. A better understanding of the molecular mechanism of TZD-induced fluid retention is essential for the development of novel therapies with improved safety profiles. An important breakthrough in the field is the finding that the renal collecting duct is a major site for increased fluid reabsorption in response to rosiglitazone or pioglitazone. New evidence also indicates that increased vascular permeability in adipose tissues may contribute to edema formation and body weight gain. Future research should therefore be directed at achieving a better understanding of the detailed mechanisms of TZD-induced increases in renal sodium transport and in vascular permeability.
format Article
id doaj-art-61afe6cca8364a8288890438457824c0
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2008-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-61afe6cca8364a8288890438457824c02025-02-03T01:00:27ZengWileyPPAR Research1687-47571687-47652008-01-01200810.1155/2008/943614943614Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid RetentionTianxin Yang0Sunhapas Soodvilai1Department of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, UT 84132-2412, USADepartment of Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, UT 84132-2412, USAThiazolidinediones (TZDs) are peroxisome proliferator-activated receptor subtype γ (PPARγ) activators that are clinically used as an insulin sensitizer for glycemic control in patients with type 2 diabetes. Additionally, TZDs exhibit novel anti-inflammatory, antioxidant, and antiproliferative properties, indicating therapeutic potential for a wide variety of diseases associated with diabetes and other conditions. The clinical applications of TZDs are limited by the common major side effect of fluid retention. A better understanding of the molecular mechanism of TZD-induced fluid retention is essential for the development of novel therapies with improved safety profiles. An important breakthrough in the field is the finding that the renal collecting duct is a major site for increased fluid reabsorption in response to rosiglitazone or pioglitazone. New evidence also indicates that increased vascular permeability in adipose tissues may contribute to edema formation and body weight gain. Future research should therefore be directed at achieving a better understanding of the detailed mechanisms of TZD-induced increases in renal sodium transport and in vascular permeability.http://dx.doi.org/10.1155/2008/943614
spellingShingle Tianxin Yang
Sunhapas Soodvilai
Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
PPAR Research
title Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
title_full Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
title_fullStr Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
title_full_unstemmed Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
title_short Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
title_sort renal and vascular mechanisms of thiazolidinedione induced fluid retention
url http://dx.doi.org/10.1155/2008/943614
work_keys_str_mv AT tianxinyang renalandvascularmechanismsofthiazolidinedioneinducedfluidretention
AT sunhapassoodvilai renalandvascularmechanismsofthiazolidinedioneinducedfluidretention